Results 71 to 80 of about 17,995 (248)
Another Microlesion Effect after STN‐DBS for Parkinson's Disease
Movement Disorders Clinical Practice, EarlyView.
Atsushi Umemura +3 more
wiley +1 more source
Neuromodulación cerebral profunda como opción terapéutica de la enfermedad de parkison idiopático en El Salvador: Informe de casos y evaluación de respuesta clínica [PDF]
, 2014 Esta tesis trata sobre la neuromodulación cerebral profunda (NCP) –que es una terapia quirúrgica- como opción para el manejo de la enfermedad de Parkinson (EP) idiopático en El Salvador, en aquellos pacientes que adolecen de esta enfermedad y, sus ...
Miguel Ortega, Gerson Eliazar +1 more
core
Treadmill Training Improves Overground Walking Economy in Parkinson’s Disease: A Randomized, Controlled Pilot Study [PDF]
, 2014 Gait disturbances are one of the principal and most incapacitating symptoms of Parkinson’s disease (PD). In addition, walking economy is impaired in PD patients and could contribute to excess fatigue in this population.
Diego Santos-GarcÃa +8 more
core +2 more sources
Parkinson’s disease managing reversible neurodegeneration
Neuropsychiatric Disease and Treatment, 2016 This paper has been retracted.Marty Hinz, 1 Alvin Stein, 2 Ted Cole, 3 Beth McDougall, 4 Mark Westaway 5 1Clinical Research, NeuroResearch Clinics, Inc., Cape Coral, FL, 2Stein Orthopedic Associates, Plantation, FL, 3Cole Center for Healing, Cincinnati,
Hinz M +4 more
doaj
PharmaceuticsLevodopa (LD) has been the most efficacious medication and the gold standard therapy for Parkinson’s disease (PD) for decades. However, its long-term administration is usually associated with motor complications, which are believed to be the result of ...
Yaocun Li +6 more
doaj +1 more source
Representation learning of drug and disease terms for drug repositioning
, 2017 Drug repositioning (DR) refers to identification of novel indications for the approved drugs. The requirement of huge investment of time as well as money and risk of failure in clinical trials have led to surge in interest in drug repositioning.
Anand, Ashish, Manchanda, Sahil
core +1 more source
Transcranial magnetic stimulation over dorsolateral prefrontal cortex in Parkinson’s disease [PDF]
, 2006 [Abstract] Objective Several studies have shown that repetitive transcranial magnetic stimulation (rTMS) over the dorsolateral prefrontal cortex (DLPFC) is effective in the treatment of depression in patients with Parkinson disease (PD).
Bello, Olalla +2 more
core +2 more sources
MedComm, Volume 7, Issue 2, February 2026.Neurons, immune cells, and other cellular components within the disease microenvironment (such as stromal cells and tumor cells) constitute a dynamically evolving ecosystem. Neurons directly modulate immune cell activity and inflammatory responses through the release of neurotransmitters (e.g., norepinephrine and CGRP), while also promoting tumor ...
Xin Guo +11 more
wiley +1 more source
Frontiers in PharmacologyBackgroundLevodopa-induced motor complications are a significant concern in the treatment of Parkinson’s disease (PD). Dopamine decarboxylase inhibitors (DCIs) such as benserazide (BSZ) and carbidopa (CD) are commonly used in conjunction with levodopa to
Huaide Qiu, Cheng Liu, Zhixiang Wang
doaj +1 more source
Clinical Endocrinology, Volume 104, Issue 2, Page 167-174, February 2026.ABSTRACT Objective To investigate the association between health literacy levels and biochemical control of hypothyroidism, measured by serum TSH and free thyroxine (FT4) levels, in patients receiving levothyroxine (L‐T4) therapy. Methods We conducted a cross‐sectional study at the Thyroid Disorders Outpatient Clinic, Escola Paulista de Medicina ...
Jessyka Krause Meneses +4 more
wiley +1 more source